sellWeak
Mel Sorensen sold $1,407 of GRTX
President and CEO at Galera Therapeutics, Inc.. 70,000 shares at an average of $0.02, traded Nov 20, 2025, filed Nov 24, 2025.
Warning score
35Value
$1,407
70,000 shares
Holdings after
195,029
-26% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$1k at market
- +10Share of holdings soldSold 26% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000905148-25-004171, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 20, 2025 | SOpen-market sale Common Stock | -70,000 | $0.02 | $1,407 | 195,029 | Nov 24, 2025 |
Related signals
Other insiders at Galera Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | GRTXbuy Galera Therapeutics, Inc. | Nancy T Chang director, owner | $500k 7,644,932 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.